PKM and neoplasm: Similarly, in nephroblastoma, platelet-derived growth factor receptor-β (PDGFR-β) activates PKM2 via the PI3K/AKT pathway, promoting glycolytic metabolism while simultaneously upregulating VEGF transcription to drive tumor angiogenesis (82).